Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making

被引:6
|
作者
Soverini, Simona [1 ]
Martelli, Margherita [1 ]
Bavaro, Luana [1 ]
De Benedittis, Caterina [1 ]
Iurlo, Alessandra [2 ]
Galimberti, Sara [3 ]
Pregno, Patrizia [4 ]
Bonifacio, Massimiliano [5 ]
Lunghi, Francesca [6 ]
Castagnetti, Fausto [1 ]
Gugliotta, Gabriele [1 ]
Rosti, Gianantonio [1 ]
Tiribelli, Mario [7 ]
Velotta, Vanessa [8 ]
Stagno, Fabio [9 ,10 ]
Rossi, Antonella Russo [11 ]
D'Adda, Mariella [12 ]
Barate, Claudia [13 ]
Crugnola, Monica [14 ]
Luciano, Luigiana [15 ]
Laginestra, Maria Antonella [16 ]
Corner, Adam S. [17 ]
Maar, Dianna [17 ]
Percesepe, Antonio [18 ]
Pileri, Stefano [19 ]
Pane, Fabrizio [20 ]
Saglio, Giuseppe [21 ]
Baccarani, Michele [22 ]
Martinelli, Giovanni [23 ]
Cavo, Michele [24 ]
机构
[1] Univ Bologna, Inst Hematol LeA Seragnoli, Bologna, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Hematol, Milan, Italy
[3] Univ Pisa, Dept Hematol, Pisa, Italy
[4] Az Osped Univ Citta Salute & Sci, Hematol Unit, Turin, Italy
[5] Univ Verona, Sect Hematol, Dept Med, Verona, Italy
[6] San Raffaele Sci Inst IRCCS, Hematol & Bone Marrow Transplant Unit, Milan, Italy
[7] Univ Udine, Div Hematol & BMT, Dept Med Area, Udine, Italy
[8] ASL Roma2, Rome, Italy
[9] AOU Policlin V Emanuele, Hematol Sect, Catania, Italy
[10] AOU Policlin V Emanuele, BMT Unit, Catania, Italy
[11] Univ Bari, Hematol, Bari, Italy
[12] ASST Spedali Civili Brescia, Dept Hematol, Brescia, Italy
[13] Univ Pisa, Dept Clin & Expt Med, Hematol, Pisa, Italy
[14] Azienda Osped Univ Parma, Div Hematol, Parma, Italy
[15] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[16] Hematopathol Sect, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[17] Digital Biol Grp, Bio Rad Labs, Peterborough, Cambs, England
[18] Univ Parma, Dept Med & Surg, Med Genet Unit, Parma, Italy
[19] European Inst Oncol, Hematopathol Unit, Milan, Italy
[20] Univ Naples Federico II, Hematol Unit, Naples, Italy
[21] AO Ordine Mauriziano, Div Univ Ematol & Terapie Cellulari, Turin, Italy
[22] St Orsola Hosp, Inst Hematol L&A Seragnoli, Bologna, Italy
[23] IRST IRCCS, Meldola, Italy
[24] Univ Bologna, Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy
关键词
D O I
10.1182/blood-2019-126767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
661
引用
收藏
页数:6
相关论文
共 33 条
  • [1] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tasar, Orcun
    Mercan, Sevcan
    Sisko, Sinem
    Khodzhaev, Khusan
    Ongoren, Seniz
    Ar, Muhlis Cem
    Baslar, Zafer
    Soysal, Teoman
    Sayitoglu, Muge
    Ozbek, Ugur
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
  • [2] Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tatonyan, Suzin Catal
    Aydin, Seniz Ongoren
    Ar, Muhlis Cem
    Baslar, Zafer
    Sayitoglu, Muge
    Ferhanoglu, A. Burhan
    Aydin, Yildiz
    Ozbek, Ugur
    Soysal, Teoman
    BLOOD, 2013, 122 (21)
  • [3] DETECTION AND MONITORING OF BCR-ABL1 KINASE DOMAIN MUTATIONS IN CML AND ALL PATIENTS BY NEXT GENERATION SEQUENCING AND DROPLET DIGITAL PCR, A BELGIAN PROSPECTIVE STUDY
    De Rop, C.
    Devos, H.
    Vannuffel, P.
    Nollet, F.
    HAEMATOLOGICA, 2017, 102 : 434 - 435
  • [4] Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
    Katerina Machova Polakova
    Vojtech Kulvait
    Adela Benesova
    Jana Linhartova
    Hana Klamova
    Monika Jaruskova
    Caterina de Benedittis
    Torsten Haferlach
    Michele Baccarani
    Giovanni Martinelli
    Tomas Stopka
    Thomas Ernst
    Andreas Hochhaus
    Alexander Kohlmann
    Simona Soverini
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 887 - 899
  • [5] Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
    Polakova, Katerina Machova
    Kulvait, Vojtech
    Benesova, Adela
    Linhartova, Jana
    Klamova, Hana
    Jaruskova, Monika
    de Benedittis, Caterina
    Haferlach, Torsten
    Baccarani, Michele
    Martinelli, Giovanni
    Stopka, Tomas
    Ernst, Thomas
    Hochhaus, Andreas
    Kohlmann, Alexander
    Soverini, Simona
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 887 - 899
  • [6] Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
    Simona Soverini
    Elisabetta Abruzzese
    Monica Bocchia
    Massimiliano Bonifacio
    Sara Galimberti
    Antonella Gozzini
    Alessandra Iurlo
    Luigiana Luciano
    Patrizia Pregno
    Gianantonio Rosti
    Giuseppe Saglio
    Fabio Stagno
    Mario Tiribelli
    Paolo Vigneri
    Giovanni Barosi
    Massimo Breccia
    Journal of Hematology & Oncology, 12
  • [7] Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
    Soverini, Simona
    Abruzzese, Elisabetta
    Bocchia, Monica
    Bonifacio, Massimiliano
    Galimberti, Sara
    Gozzini, Antonella
    Iurlo, Alessandra
    Luciano, Luigiana
    Pregno, Patrizia
    Rosti, Gianantonio
    Saglio, Giuseppe
    Stagno, Fabio
    Tiribelli, Mario
    Vigneri, Paolo
    Barosi, Giovanni
    Breccia, Massimo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [8] Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
    Kim, Yeojae
    Kim, Seongkoo
    Lee, Jong Mi
    Ahn, Ari
    Yoo, Jae Won
    Lee, Jae Wook
    Cho, Bin
    Chung, Nack-Gyun
    Kim, Yonggoo
    Kim, Myungshin
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [9] Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia
    Simona Soverini
    Sara De Santis
    Margherita Martelli
    Cecilia Monaldi
    Fausto Castagnetti
    Gabriele Gugliotta
    Cristina Papayannidis
    Manuela Mancini
    Samantha Bruno
    Claudia Venturi
    Katerina Machova Polakova
    Thomas Ernst
    Dianna Maar
    Adam Corner
    Michele Cavo
    Leukemia, 2022, 36 : 2250 - 2260
  • [10] Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia
    Soverini, Simona
    De Santis, Sara
    Martelli, Margherita
    Monaldi, Cecilia
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Papayannidis, Cristina
    Mancini, Manuela
    Bruno, Samantha
    Venturi, Claudia
    Polakova, Katerina Machova
    Ernst, Thomas
    Maar, Dianna
    Corner, Adam
    Cavo, Michele
    LEUKEMIA, 2022, 36 (09) : 2250 - 2260